Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy

Abstract

Lifetime risk of developing colorectal cancer is 5%, and 5-year survival at early stage is 92%. Individuals with precancerous lesions removed at primary screening are typically recommended surveillance colonoscopy. Because greater benefits are anticipated for those with higher risk of colorectal cancer, scope for risk-specific surveillance recommendations exists. This review assesses published cost-effectiveness estimates of postpolypectomy surveillance to consider the potential for personalized recommendations by risk group. Meta-analyses of incidence of advanced neoplasia postpolypectomy for low-risk cases were comparable to those without adenoma, with both rates under the lifetime risk of 5%. This group may not benefit from intensive surveillance, which risks unnecessary harm and inefficient use of often scarce colonoscopy capacity. Therefore, greater personalization through deintensified strategies for low-risk individuals could be beneficial. The potential for noninvasive testing, such as fecal immunochemical tests, combined with primary prevention or chemoprevention may reserve colonoscopy for targeted use in personalized risk-stratified surveillance. This review appraised evidence supporting a program of personalized surveillance in patients with colorectal adenoma according to risk group and compared the effectiveness of surveillance colonoscopy with alternative prevention strategies. It assessed trade-offs among costs, benefits, and adverse effects that must be considered in a decision to adopt or reject personalized surveillance.

BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway

“…Colorectal cancer (CRC) is the third most prevalent cancer worldwide (McFerran et al, ). Both the rate of incidence and mortality in terms of CRC ranked in the top of five in Chinese cancer population (Chen et al, ; Fan, Huang, Zhuang, Ai & Sun, ).…”

Reducing the number of surveillance colonoscopies with faecal immunochemical tests

“…Nonetheless, these data presented raise the possibility of using FIT to improve utilisation of limited colonoscopy resources. The majority of individuals undergoing surveillance colonoscopy have no significant pathology, suggesting an over-service of these individuals 5. We would propose an alternative of using the quantitative FIT value (as opposed to binary positive/negative result) to personalise the frequency of colonoscopy rather than omit colonoscopy altogether.…”

Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression

“…The staining intensity of colon cancer cells was scored as negative (0), weak (1), moderate (2), and strong (3). The percentages of positively stained cells were graded as follows: <5% (0), 5-25% (1), 25-50% (2), 50-75% (3), ≥75% (4).…”

“…Colorectal cancer (CRC) is the most commonly diagnosed malignancy and the third leading cause of cancer-related death worldwide 1,2 . Despite that CRC screening and therapy have been improved, mortality rates have failed to decrease significantly 3,4 .…”